Besides VEGF activity, the mammalian target of rapamycin (mTOR) signaling pathway also plays a central role in regulation of cell proliferation, migration, survival, and angiogenesis, which represents a promising target with respect to its frequent dysregulation in HCC. The gene discussed is MTOR; the disease is hepatocellular carcinoma.